Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium
October 20, 2026
October 20, 2026
BOSTON, Massachusetts, Oct. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium
*
Additional key study updates in prostate, breast and kidney cancer, and a special symposium focused on personalized cancer vaccines
Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society . . .
* * *
Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium
*
Additional key study updates in prostate, breast and kidney cancer, and a special symposium focused on personalized cancer vaccines
Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society . . .
